iodine and su 11248
iodine has been researched along with su 11248 in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Beck-Peccoz, P; Bertuelli, R; Carletto, M; Casali, PG; Coco, P; Fugazzola, L; Mannavola, D; Vannucchi, G | 1 |
Bauman, JE; Capell, PT; Carr, LL; Eaton, KD; Goulart, BH; Kell, EM; Mankoff, DA; Martins, RG | 1 |
Casuscelli, J; Graser, A; Hellbach, K; Hummel, N; Ingrisch, M; Karpitschka, M; Schlemmer, M; Sommer, W; Staehler, M; Sterzik, A | 1 |
Adriaansz, S; Beijnen, JH; Blank, CU; Huitema, AD; Lankheet, NA; Mallo, H; Rosing, H; Schellens, JH | 1 |
Adriaansz, S; Beijnen, JH; Blank, CU; Haanen, JB; Huitema, AD; Lankheet, NA; Mallo, H; Schellens, JH | 1 |
Trials
3 trial(s) available for iodine and su 11248
Article | Year |
---|---|
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake.
Topics: Adult; Aged; Biological Transport; Female; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Indoles; Iodine; Iodine Radioisotopes; Male; Middle Aged; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Thyrotropin | 2007 |
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Cell Differentiation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Pyrroles; Sunitinib; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2010 |
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand-foot syndrome.
Topics: Aged; Antineoplastic Agents; Female; Hand-Foot Syndrome; Humans; Indoles; Male; Middle Aged; Pyrroles; Seasons; Sunitinib; Sweat | 2013 |
Other Studies
2 other study(ies) available for iodine and su 11248
Article | Year |
---|---|
Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer.
Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Indoles; Iodine; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Biotransformation; Calibration; Carcinoma, Renal Cell; Chromatography, High Pressure Liquid; Dealkylation; Drug Administration Schedule; Female; Hand-Foot Syndrome; Humans; Indoles; Kidney Neoplasms; Limit of Detection; Protein Kinase Inhibitors; Pyrroles; Reproducibility of Results; Sunitinib; Sweat; Tandem Mass Spectrometry | 2011 |